Company Encyclopedia
View More
name
Agilent Tech
A.US
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
770.89 B
A.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Life Sciences Tools and ServicesIndustry
Industry Ranking3/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE20.62%A
    • Profit Margin18.75%A
    • Gross Margin52.43%B
  • Growth ScoreC
    • Revenue YoY6.73%C
    • Net Profit YoY1.09%C
    • Total Assets YoY7.44%B
    • Net Assets YoY14.29%A
  • Cash ScoreC
    • Cash Flow Margin533.23%C
    • OCF YoY6.73%C
  • Operating ScoreB
    • Turnover0.57B
  • Debt ScoreC
    • Gearing Ratio47.03%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks?

    How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks?

    Barchart Option·
    US
    A
    -0.63%
    Barchart Option·
    US
    A
    -0.63%

    Jim Cramer on Agilent: "The thing's just caught fire"

    Jim Cramer recently discussed Agilent Technologies, Inc. (NYSE:A), highlighting its strong long-term performance. He referred to the company as an 'arms dealer' to the life sciences industry, indicating its significant role and impact in the sector.

    MSN·
    US
    A
    -0.63%
    MSN·
    US
    A
    -0.63%

    Dir Dolsten Sells 2,600 ($389.5K) Of Agilent Technologies Inc [A]

    Dolsten Mikael Director of Agilent Technologies Inc [A] filed a Form 4 on December 3, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/1/25TransactionSaleShares2,600Price$149.81Value$389,511Ending Holdings: 4,973 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

    Reuters·
    US
    A
    -0.63%
    Reuters·
    US
    A
    -0.63%

    Agilent Technologies Director Mikael Dolsten Reports Sale of Common Shares

    Mikael Dolsten, Director at Agilent Technologies Inc., reported the sale of common shares. The information was published via EDGAR by the U.S. Securities and Exchange Commission on December 03, 2025. This brief is AI-generated by Public Technologies and is not financial advice.

    Reuters·
    US
    A
    -0.63%
    Reuters·
    US
    A
    -0.63%

    Agilent, Waters Face Diverging Outlooks on Growth and Integration Risks, Morgan Stanley Says

    Agilent, Waters Face Diverging Outlooks on Growth and Integration Risks, Morgan Stanley Says

    marketscreener·
    US
    A
    -0.63%
    US
    WAT
    -0.31%
    marketscreener·
    US
    A
    -0.63%
    US
    WAT
    -0.31%
    Posts
    View More

    To begin with, my personal view is that the Federal Reserve continues to make mistakes. Next week, the U.S. stock market may still face troubles. $Tesla(TSLA.US) Data analysis and interpretation 1. Ov...

    • 0
    • 1

    According to Huang's understanding, the development of artificial intelligence is divided into four stages.

    The first stage is called perceptual artificial intelligence, which includes speech recogniti...............
    • 0
    © 2025 Longbridge｜Disclaimer